亚太丝路投资(00767.HK)签订战略合作夥伴关系备忘录 开发长寿科学业务技术
亚太丝路投资(00767.HK)公布,公司与赛默飞世尔签订关於发展战略合作夥伴关系的备忘录,双方同意建立战略合作夥伴关系,在探索、开发与分析生物标记在长寿医学及健康研究的应用范围内的其他相关领域战略合作,开发技术方法,解决方案和服务产品。
备忘录初步合作期限为三年。如任何一方未在备忘录期满前一个月内提出书面异议,则备忘录将在到期後自动续期一年,最长有效期不超过五年。
赛默飞世尔将为公司优先提供该公司最新技术方法、软件和解决方案。这些技术对於公司发展长寿科学业务的至关重要。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.